These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 19175322)

  • 1. Synthesis and analysis of novel glycerolipids for the treatment of metabolic syndrome.
    Jorgensen MR; Bhurruth-Alcor Y; Røst T; Bohov P; Müller M; Guisado C; Kostarelos K; Dyrøy E; Berge RK; Miller AD; Skorve J
    J Med Chem; 2009 Feb; 52(4):1172-9. PubMed ID: 19175322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel phospholipid analogues of pan-PPAR activator tetradecylthioacetic acid are more PPAR alpha selective.
    Bhurruth-Alcor Y; Rost TH; Jorgensen MR; Rajender ; Müller M; Skorve J; Berge RK; Miller AD
    Bioorg Med Chem Lett; 2010 Feb; 20(3):1252-5. PubMed ID: 20036122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PPAR agonists and the metabolic syndrome.
    Staels B
    Therapie; 2007; 62(4):319-26. PubMed ID: 17983557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of mitochondrial biogenesis and respiration is associated with mTOR regulation in hepatocytes of rats treated with the pan-PPAR activator tetradecylthioacetic acid (TTA).
    Hagland HR; Nilsson LI; Burri L; Nikolaisen J; Berge RK; Tronstad KJ
    Biochem Biophys Res Commun; 2013 Jan; 430(2):573-8. PubMed ID: 23228666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary modulators of peroxisome proliferator-activated receptors: implications for the prevention and treatment of metabolic syndrome.
    Guri AJ; Hontecillas R; Bassaganya-Riera J
    J Nutrigenet Nutrigenomics; 2008; 1(3):126-35. PubMed ID: 19776622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. S26948, a new specific peroxisome proliferator activated receptor gamma modulator improved in vivo hepatic insulin sensitivity in 48 h lipid infused rats.
    Sohn KA; Cruciani-Guglielmacci C; Kassis N; Clément L; Ouali F; Caüzac M; Lebègue N; Berthelot P; Caignard DH; Pégorier JP; Renard P; Dacquet C; Ktorza A; Magnan C;
    Eur J Pharmacol; 2009 Apr; 608(1-3):104-11. PubMed ID: 19250932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The molecular structure of thio-ether fatty acids influences PPAR-dependent regulation of lipid metabolism.
    Lund J; Stensrud C; Rajender ; Bohov P; Thoresen GH; Berge RK; Wright M; Kamal A; Rustan AC; Miller AD; Skorve J
    Bioorg Med Chem; 2016 Mar; 24(6):1191-203. PubMed ID: 26874397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of nutritional vitamin A deficiency on lipid metabolism in the rat heart: Its relation to PPAR gene expression.
    Vega VA; Anzulovich AC; Varas SM; Bonomi MR; Giménez MS; Oliveros LB
    Nutrition; 2009; 25(7-8):828-38. PubMed ID: 19342198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting peroxisome proliferator-activated receptors (PPARs): development of modulators.
    Pirat C; Farce A; Lebègue N; Renault N; Furman C; Millet R; Yous S; Speca S; Berthelot P; Desreumaux P; Chavatte P
    J Med Chem; 2012 May; 55(9):4027-61. PubMed ID: 22260081
    [No Abstract]   [Full Text] [Related]  

  • 10. Differential effects of in vivo PPAR alpha and gamma activation on fatty acid transport proteins expression and lipid content in rat liver.
    Wierzbicki M; Chabowski A; Zendzian-Piotrowska M; Gorski J
    J Physiol Pharmacol; 2009 Mar; 60(1):99-106. PubMed ID: 19439812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxisome proliferator-activated receptor alpha activation induces unfavourable changes in fatty acid composition of myocardial phospholipids.
    Baranowski M; Blachnio-Zabielska A; Gorski J
    J Physiol Pharmacol; 2009 Jun; 60(2):13-20. PubMed ID: 19617640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of peroxisome proliferator-activated receptor-gamma potentiates pro-inflammatory cytokine production, and adrenal and somatotropic changes of weaned pigs after Escherichia coli lipopolysaccharide challenge.
    Liu Y; Shi J; Lu J; Meng G; Zhu H; Hou Y; Yin Y; Zhao S; Ding B
    Innate Immun; 2009 Jun; 15(3):169-78. PubMed ID: 19474210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pan-PPAR agonist beneficial effects in overweight mice fed a high-fat high-sucrose diet.
    Fernandes-Santos C; Carneiro RE; de Souza Mendonca L; Aguila MB; Mandarim-de-Lacerda CA
    Nutrition; 2009; 25(7-8):818-27. PubMed ID: 19268533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short term 13-cis-retinoic acid treatment at therapeutic doses elevates expression of leptin, GLUT4, PPARgamma and aP2 in rat adipose tissue.
    Krskova-Tybitanclova K; Macejova D; Brtko J; Baculikova M; Krizanova O; Zorad S
    J Physiol Pharmacol; 2008 Dec; 59(4):731-43. PubMed ID: 19212007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PPAR activators and COX inhibitors selectively block cytokine-induced COX-2 expression and activity in human aortic smooth muscle cells.
    Rival Y; Puech L; Taillandier T; Benéteau N; Rouquette A; Lestienne F; Dupont-Passelaigue E; Le Roy I; Patoiseau JF; Junquéro D
    Eur J Pharmacol; 2009 Mar; 606(1-3):121-9. PubMed ID: 19374865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medium-chain fatty acids ameliorate insulin resistance caused by high-fat diets in rats.
    Wein S; Wolffram S; Schrezenmeir J; Gasperiková D; Klimes I; Seböková E
    Diabetes Metab Res Rev; 2009 Feb; 25(2):185-94. PubMed ID: 19219861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of combined olmesartan and pravastatin on glucose intolerance and cardiovascular remodeling in a metabolic-syndrome model.
    Mizukawa M; Ohmori K; Obayashi A; Ishihara Y; Yoshida J; Noma T; Yukiiri K; Kosaka H; Kohno M
    Hypertens Res; 2009 Jul; 32(7):617-24. PubMed ID: 19461650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modifying the n-6/n-3 polyunsaturated fatty acid ratio of a high-saturated fat challenge does not acutely attenuate postprandial changes in inflammatory markers in men with metabolic syndrome.
    Tulk HM; Robinson LE
    Metabolism; 2009 Dec; 58(12):1709-16. PubMed ID: 19625064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, attenuates acrolein-induced airway mucus hypersecretion in rats.
    Liu DS; Liu WJ; Chen L; Ou XM; Wang T; Feng YL; Zhang SF; Xu D; Chen YJ; Wen FQ
    Toxicology; 2009 Jun; 260(1-3):112-9. PubMed ID: 19464576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of insulin resistance on endothelial progenitor cells and vascular repair.
    Cubbon RM; Kahn MB; Wheatcroft SB
    Clin Sci (Lond); 2009 Aug; 117(5):173-90. PubMed ID: 19630751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.